IRIS BioTechnologies Inc. Information

Iris BioTechnologies has been perfecting the 21st Century tools necessary to bring P4 medicine to the clinic. Iris’s state-of-the-art Nano-biochips™ and BioWindows™ medical informatics system are capable of capturing and analyzing the many alterations in cancer pathways by capturing mRNA, microRNA, proteins or other biomarkers. Our patented products were developed to overcome the sensitivity, specificity, speed and cost limitations of present state-of-the-art microarray technology. The Iris products are designed to be FDA approved, enabling them to be used in any certified laboratory in the United States.